Top Story

NIH awards seven research grants for vaccine adjuvants

October 18, 2014

The National Institute of Allergy and Infectious Diseases, a division of the NIH, has awarded seven research grants to separate institutions to explore and develop new adjuvants to enhance the effectiveness of existing and future vaccines.

“The goal of this research is to identify novel adjuvant candidates that safely and selectively boost vaccine-induced immune responses,” Anthony S. Fauci, MD, NIAID director, said in a press release. “Such adjuvants could be used to improve current vaccines, extend the vaccine supply or enhance vaccine efficacy in people with immature or weakened immune systems, such as infants and the elderly.”

$5.8 million contract awarded for development of third Ebola vaccine

October 17, 2014
The US Department of Health and Human Services announced a $5.8 million contract toward the development of a third Ebola vaccine, according to a press release.The…
In the Journals

Vaccination coverage rates high among US kindergarteners

October 16, 2014
Routine vaccination coverage among children in kindergarten was at or near the 95% national Healthy People 2020 target for DTaP, measles-mumps-rubella and…
figure In the Journals

Current tobacco use associated with oral HPV-16 infection

October 14, 2014
Researchers identified a significant relationship between oral HPV-16 infection and behavioral and objective biomarkers of current tobacco use, according to data…
More News Headlines »